HEALTH CARE UTILIZATION AND COSTS AFTER WARFARIN DISCONTINUATION AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

被引：0
|
作者：
Wang, J. [1 ]
Qiao, Y. [1 ]
Spivey, C. A. [1 ]
Liu, X. [2 ]
Phatak, H. [3 ]
Mardekian, J. [4 ]
Claflin, A. B. [4 ]
Kachroo, S. [3 ]
Abdulsatter, Y. [4 ]
Parker, R. B. [1 ]
机构：
[1] Univ Tennessee, Coll Pharm, Memphis, TN USA
[2] Univ Tennessee, Coll Pharm, New York, NY USA
[3] Bristol Myers Squibb Co, Princeton, NJ USA
[4] Pfizer Inc, New York, NY USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.230
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV4
引用
收藏
页码：A756 / A756
页数：1
相关论文
共 50 条
  • [1] WARFARIN DISCONTINUATION AND STROKE RISK AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Wang, J.
    Qiao, Y.
    Spivey, C. A.
    Liu, X.
    Phatak, H.
    Mardekian, J.
    Claflin, A. B.
    Kachroo, S.
    Abdulsatter, Y.
    Parker, R. B.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A8 - A9
  • [2] Predictors of warfarin discontinuation or switching among non-valvular atrial fibrillation patients
    Lip, G. Y. H.
    Keshishian, A.
    Li, X.
    Lee, T. C.
    Mardekian, J.
    Posner, N.
    Luo, X.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 774 - 775
  • [3] DISCONTINUATION/INTERRUPTION OF WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Wang, J.
    Qiao, Y.
    Spivey, C. A.
    Liu, X.
    Phatak, H.
    Mardekian, J.
    Claflin, A. B.
    Kachroo, S.
    Abdulsatter, Y.
    Parker, R. B.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A763 - A763
  • [4] DISCONTINUATION AND HEALTH CARE RESOURCE UTILISATION IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS TREATED WITH APIXABAN OR WARFARIN IN ENGLAND
    Graham, S.
    Raluy-Callado, M.
    Donaldson, R.
    Colby, C.
    Carroll, R.
    Nordstrom, B.
    Stynes, G.
    Hill, N.
    Ramagopalan, S.
    Alikhan, R.
    [J]. VALUE IN HEALTH, 2018, 21 : S112 - S112
  • [5] Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation
    Nelson, Winnie W.
    Song, Xue
    Coleman, Craig I.
    Thomson, Erin
    Smith, David M.
    Damaraju, C. V.
    Schein, Jeffrey R.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (12) : 2461 - 2469
  • [6] Utilization of warfarin in elderly patients with non-valvular atrial fibrillation.
    Youssef, H
    Pomerantz, SC
    Ciesielski, J
    Cavalieri, TA
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S112 - S112
  • [7] Warfarin in non-valvular atrial fibrillation
    Dalby, A. J.
    Wessels, P.
    Opie, L. H.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2013, 103 (12): : 901 - 904
  • [8] Warfarin utilization and stroke risk in patients with chronic non-valvular atrial fibrillation
    Boccuzzi, SJ
    Stephenson, JJ
    Kreilick, CA
    Beaulieu, JF
    Hauch, O
    Kim, J
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 335A - 335A
  • [9] COMPARISON OF MAJOR BLEEDING RELATED MORTALITY, HEALTH CARE UTILIZATION AND COSTS OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Baser, O.
    Du, J.
    Xie, L.
    Baser, E.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A38 - A38
  • [10] Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?
    Laliberte, Francois
    Pilon, Dominic
    Raut, Monika K.
    Nelson, Winnie W.
    Olson, William H.
    Germain, Guillaume
    Schein, Jeff R.
    Lefebvre, Patrick
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (08) : 1521 - 1528
12345